Astral Limited is set to acquire an 80% equity stake in NEXELON CHEM PRIVATE LIMITED.

This strategic move aims to enable in-house manufacturing of CPVC resin, a critical raw material.

The acquisition is expected to drive significant cost optimization and enhance profit margins for Astral.

The company plans to invest up to Rs. 120 Cr into NEXELON over time, with the transaction anticipated to close within 2-3 months.

This is a clear step towards vertical integration and improved operational efficiency.